PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) is set to present significant advancements in cancer treatment at ...

Poster abstract submissions for the 2024 Johns Hopkins Research Symposium on Engineering in Healthcare are being accepted through Nov. 3 ...

INOVIO (NASDAQ: INO) is set to highlight its latest research in immunotherapy at several prestigious scientific conferences ...

We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not ...

(NYSE: PFE) will present data across its infectious disease portfolio at the upcoming IDWeek 2024 congress, held in Los Angeles ...

Kineta, Inc. (OTC Pink: KANT) , a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that its ...

The 17th annual Neuroscience Research Day at the Jacobs School of Medicine and Biomedical Sciences on Sept. 26 was filled with an aura of warmth and positivity.

Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the EADV 2024 Congress ...

An additional featured poster describes the ... The details of the presentations are as follows: Oral Presentation Selected as one of the top research abstracts at the symposium, Dr. Bakhru ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...